BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31028441)

  • 1. Differentiating focal autoimmune pancreatitis and pancreatic ductal adenocarcinoma: contrast-enhanced MRI with special emphasis on the arterial phase.
    Kwon JH; Kim JH; Kim SY; Byun JH; Kim HJ; Lee MG; Lee SS
    Eur Radiol; 2019 Nov; 29(11):5763-5771. PubMed ID: 31028441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic duct "Icicle sign" on MRI for distinguishing autoimmune pancreatitis from pancreatic ductal adenocarcinoma in the proximal pancreas.
    Kim HJ; Kim YK; Jeong WK; Lee WJ; Choi D
    Eur Radiol; 2015 Jun; 25(6):1551-60. PubMed ID: 25501271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiating Mass-Forming Autoimmune Pancreatitis From Pancreatic Ductal Adenocarcinoma on the Basis of Contrast-Enhanced MRI and DWI Findings.
    Choi SY; Kim SH; Kang TW; Song KD; Park HJ; Choi YH
    AJR Am J Roentgenol; 2016 Feb; 206(2):291-300. PubMed ID: 26797355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focal autoimmune pancreatitis: radiological characteristics help to distinguish from pancreatic cancer.
    Sun GF; Zuo CJ; Shao CW; Wang JH; Zhang J
    World J Gastroenterol; 2013 Jun; 19(23):3634-41. PubMed ID: 23801866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of dynamic contrast-enhanced magnetic resonance imaging in the differentiation of pancreatic ductal adenocarcinoma from other pancreatic solid lesions.
    Liu K; Xie P; Peng W; Zhou Z
    J Comput Assist Tomogr; 2014; 38(5):681-6. PubMed ID: 24943251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of mass-forming focal pancreatitis from pancreatic ductal adenocarcinoma: value of characterizing dynamic enhancement patterns on contrast-enhanced MR images by adding signal intensity color mapping.
    Kim M; Jang KM; Kim JH; Jeong WK; Kim SH; Kang TW; Kim YK; Cha DI; Kim K
    Eur Radiol; 2017 Apr; 27(4):1722-1732. PubMed ID: 27510628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma using magnetic resonance imaging: The value of contrast-enhanced and diffusion weighted imaging.
    Guo C; Chen X; Wang Z; Xiao W; Wang Q; Sun K; Zhuge X
    Oncotarget; 2017 Jun; 8(26):42962-42973. PubMed ID: 28487490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic duct abnormalities in focal autoimmune pancreatitis: MR/MRCP imaging findings.
    Negrelli R; Manfredi R; Pedrinolla B; Boninsegna E; Ventriglia A; Mehrabi S; Frulloni L; Pozzi Mucelli R
    Eur Radiol; 2015 Feb; 25(2):359-67. PubMed ID: 25106489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of focal-type autoimmune pancreatitis from pancreatic carcinoma: assessment by multiphase contrast-enhanced CT.
    Furuhashi N; Suzuki K; Sakurai Y; Ikeda M; Kawai Y; Naganawa S
    Eur Radiol; 2015 May; 25(5):1366-74. PubMed ID: 25433412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase diagnostic accuracy in differentiating focal type autoimmune pancreatitis from pancreatic cancer with combined serum IgG4 and CA19-9 levels.
    Chang MC; Liang PC; Jan S; Yang CY; Tien YW; Wei SC; Wong JM; Chang YT
    Pancreatology; 2014; 14(5):366-72. PubMed ID: 25278306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune pancreatitis: imaging findings on contrast-enhanced MR, MRCP and dynamic secretin-enhanced MRCP.
    Carbognin G; Girardi V; Biasiutti C; Camera L; Manfredi R; Frulloni L; Hermans JJ; Mucelli RP
    Radiol Med; 2009 Dec; 114(8):1214-31. PubMed ID: 19789959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and treatment of autoimmune pancreatitis types 1 and 2.
    Fritz S; Bergmann F; Grenacher L; Sgroi M; Hinz U; Hackert T; Büchler MW; Werner J
    Br J Surg; 2014 Sep; 101(10):1257-65. PubMed ID: 25047016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and imaging features of autoimmune pancreatitis with focal pancreatic swelling or mass formation: comparison with so-called tumor-forming pancreatitis and pancreatic carcinoma.
    Wakabayashi T; Kawaura Y; Satomura Y; Watanabe H; Motoo Y; Okai T; Sawabu N
    Am J Gastroenterol; 2003 Dec; 98(12):2679-87. PubMed ID: 14687817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristic magnetic resonance features of focal autoimmune pancreatitis useful for differentiation from pancreatic cancer.
    Sugiyama Y; Fujinaga Y; Kadoya M; Ueda K; Kurozumi M; Hamano H; Kawa S
    Jpn J Radiol; 2012 May; 30(4):296-309. PubMed ID: 22237599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast-Enhanced Endoscopic Ultrasound for Differentially Diagnosing Autoimmune Pancreatitis and Pancreatic Cancer.
    Cho MK; Moon SH; Song TJ; Kim RE; Oh DW; Park DH; Lee SS; Seo DW; Lee SK; Kim MH
    Gut Liver; 2018 Sep; 12(5):591-596. PubMed ID: 29699060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct pathophysiological cytokine profiles for discrimination between autoimmune pancreatitis, chronic pancreatitis, and pancreatic ductal adenocarcinoma.
    Ghassem-Zadeh S; Gaida MM; Szanyi S; Acha-Orbea H; Frossard JL; Hinz U; Hackert T; Strobel O; Felix K
    J Transl Med; 2017 Jun; 15(1):126. PubMed ID: 28578701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel quantitative perfusion analysis with contrast-enhanced harmonic EUS for differentiation of autoimmune pancreatitis from pancreatic carcinoma.
    Imazu H; Kanazawa K; Mori N; Ikeda K; Kakutani H; Sumiyama K; Hino S; Ang TL; Omar S; Tajiri H
    Scand J Gastroenterol; 2012 Jul; 47(7):853-60. PubMed ID: 22507131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Missed pancreatic ductal adenocarcinoma: Assessment of early imaging findings on prediagnostic magnetic resonance imaging.
    Jang KM; Kim SH; Kim YK; Song KD; Lee SJ; Choi D
    Eur J Radiol; 2015 Aug; 84(8):1473-1479. PubMed ID: 26032128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiating autoimmune pancreatitis from pancreatic adenocarcinoma using dual-phase computed tomography.
    Zaheer A; Singh VK; Akshintala VS; Kawamoto S; Tsai SD; Gage KL; Fishman EK
    J Comput Assist Tomogr; 2014; 38(1):146-52. PubMed ID: 24424563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18-Fluorodeoxyglucose positron emission tomography does not aid in diagnosis of pancreatic ductal adenocarcinoma.
    Matsumoto I; Shirakawa S; Shinzeki M; Asari S; Goto T; Ajiki T; Fukumoto T; Kitajima K; Ku Y
    Clin Gastroenterol Hepatol; 2013 Jun; 11(6):712-8. PubMed ID: 23353642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.